Search

Search Constraints

You searched for: Date 2022 Author/Creator Resche-Rigon, Matthieu

Search Results

3. PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study. Issue 4 (April 2022)

5. Risk factors of long term symptoms and outcomes among patients discharged after covid-19: prospective, multicentre observational study. Issue 1 (20th June 2022)

6. Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study. (February 2022)

7. Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial. (January 2022)

8. Tocilizumab plus dexamethasone versus dexamethasone in patients with moderate-to-severe COVID-19 pneumonia: A randomised clinical trial from the CORIMUNO-19 study group. (April 2022)